Rosenbaum Paula F, Buck Germaine M, Brecher Martin L
Center for Outcomes Research and Evaluation, State University of New York Upstate Medical University, Syracuse, NY 13210, USA.
Paediatr Perinat Epidemiol. 2005 Mar;19(2):152-64. doi: 10.1111/j.1365-3016.2005.00634.x.
Infectious disease histories were evaluated in a population-based case-control study of childhood acute lymphoblastic leukaemia (ALL) as it has been hypothesised that delays in early infections are associated with an increased risk of disease. Allergy histories were also assessed as part of a broader evaluation of the role of immune factors in ALL. Cases (n = 255) were diagnosed between 1980 and 1991 at one of four referral centres in a 31-county area of New York State; controls (n = 760) were a random sample of live births from the same region, frequency matched to cases by sex, race and birth year. Data were collected by mailed questionnaire, completed by case and control parents in 1995. Allergy and infectious histories before the age at leukaemia diagnosis for cases and an equivalent age for controls were evaluated. The adjusted odds ratio and 95% confidence interval [CI] associated with a positive history of any allergy was 0.58 [95% CI 0.38, 0.88] compared with a negative allergy history. The occurrence of several common childhood illnesses before 25 months of age and ALL were assessed, with both weak positive and weak inverse associations observed. Overall, these analyses provide little support for the hypothesis that infection delay in early life is associated with an increased risk of ALL. Children with positive allergy histories reported significantly more infections than those with negative histories; however, effect modification of the infection-ALL associations by child allergy history was not observed. Nonetheless, these observations suggest the importance of assessing both allergy and infectious histories and their possible interactions when evaluating the association between these immune factors and childhood ALL.
在一项基于人群的儿童急性淋巴细胞白血病(ALL)病例对照研究中,对传染病史进行了评估,因为有假设认为早期感染的延迟与疾病风险增加有关。过敏史也作为对免疫因素在ALL中作用的更广泛评估的一部分进行了评估。病例(n = 255)于1980年至1991年期间在纽约州31个县地区的四个转诊中心之一被诊断;对照(n = 760)是来自同一地区的活产随机样本,按性别、种族和出生年份与病例进行频率匹配。数据通过邮寄问卷收集,由病例和对照的父母于1995年完成。评估了病例白血病诊断年龄之前以及对照相同年龄时的过敏和传染病史。与阴性过敏史相比,任何过敏阳性史的调整后比值比和95%置信区间[CI]为0.58 [95% CI 0.38, 0.88]。评估了25个月龄之前几种常见儿童疾病的发生情况与ALL的关系,观察到既有弱阳性关联也有弱反向关联。总体而言,这些分析几乎没有支持早期生命中感染延迟与ALL风险增加相关的假设。过敏史阳性的儿童报告的感染明显多于过敏史阴性的儿童;然而,未观察到儿童过敏史对感染与ALL关联的效应修正。尽管如此,这些观察结果表明,在评估这些免疫因素与儿童ALL之间的关联时,评估过敏和传染病史及其可能的相互作用非常重要。